Get Premium to unlock powerful stock data
NAS:ABEO (USA)  
Abeona Therapeutics Inc logo

Abeona Therapeutics Inc

$ 4.08 -0.71 (-14.82%) 08:08 PM EST
P/E:
At Loss
P/B:
0.86
Market Cap:
$ 23.99M
Enterprise V:
$ 5.94M
Volume:
473.32K
Avg Vol (2M):
69.45K
Also Trade In:
Volume:
473.32K
Market Cap $:
23.99M
PE Ratio:
At Loss
Avg Vol (2-Month):
69.45K
Enterprise Value $:
5.94M
PB Ratio:
0.86
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Abeona Therapeutics Inc
NAICS : 325413 SIC : 2834
1330 Avenue of the Americas, 33rd Floor, New York, NY, USA, 10019
Description
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its lead clinical programs consist of EB-101, autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, adeno-associated virus-based gene therapy for Sanfilippo syndrome type A, and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B.
Name Current Vs Industry Vs History
Cash-To-Debt 3.44
Equity-to-Asset 0.57
Debt-to-Equity 0.29
Debt-to-EBITDA -0.11
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -21.03
Distress
Grey
Safe
Beneish M-Score -3.26
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 56.06
9-Day RSI 58.34
14-Day RSI 55.95
6-1 Month Momentum % -50.23
12-1 Month Momentum % -89.72

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.18
Quick Ratio 3.18
Cash Ratio 2.54
Days Sales Outstanding 327.26

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -45.3

Financials (Next Earnings Date:2022-07-28 Est.)

ABEO's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ABEO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 3.346
EPS (TTM) ($) -20.5
Beta 1.24
Volatility % 78.03
14-Day RSI 55.95
14-Day ATR ($) 0.021571
20-Day SMA ($) 0.172015
12-1 Month Momentum % -89.72
52-Week Range ($) 3.2575 - 38.875
Shares Outstanding (Mil) 5.88

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Abeona Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More